Update on primary sclerosing cholangitis.
作者信息
Chapman Roger W
机构信息
Nuffield Department of Medicine Oxford University Oxford United Kingdom.
Translational Gastroenterology Unit John Radcliffe Hospital Oxford United Kingdom.
出版信息
Clin Liver Dis (Hoboken). 2017 May 26;9(5):107-110. doi: 10.1002/cld.633. eCollection 2017 May.
Abstract
摘要
相似文献
1
Update on primary sclerosing cholangitis.原发性硬化性胆管炎的最新进展。
Clin Liver Dis (Hoboken). 2017 May 26;9(5):107-110. doi: 10.1002/cld.633. eCollection 2017 May.
2
An update on primary sclerosing cholangitis.原发性硬化性胆管炎的最新进展。
Curr Opin Gastroenterol. 2008 May;24(3):377-83. doi: 10.1097/MOG.0b013e3282f9e239.
3
Primary sclerosing cholangitis: a clinical update.原发性硬化性胆管炎：临床新进展。
Br Med Bull. 2015 Jun;114(1):53-64. doi: 10.1093/bmb/ldv019. Epub 2015 May 16.
4
Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis.原发性硬化性胆管炎合并口疮样结肠炎，难以与IgG4相关性硬化性胆管炎相鉴别。
Case Rep Gastroenterol. 2022 Feb 7;16(1):23-28. doi: 10.1159/000521538. eCollection 2022 Jan-Apr.
5
Surgery for segmental primary sclerosing cholangitis.节段性原发性硬化性胆管炎的手术治疗
Hepatogastroenterology. 2004 May-Jun;51(57):668-71.
6
Primary Sclerosing Cholangitis, Small Duct Primary Sclerosing Cholangitis, IgG4-Related Sclerosing Cholangitis, and Ischemic Cholangiopathy: Diagnostic Challenges on Biopsy.原发性硬化性胆管炎、小胆管原发性硬化性胆管炎、IgG4 相关硬化性胆管炎和缺血性胆管病：活检的诊断挑战。
Surg Pathol Clin. 2023 Sep;16(3):533-548. doi: 10.1016/j.path.2023.04.008. Epub 2023 Jun 9.
7
Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?慢性溃疡性结肠炎中的胆管周围炎：小胆管的原发性硬化性胆管炎？
Ann Intern Med. 1985 May;102(5):581-7. doi: 10.7326/0003-4819-102-5-581.
8
Primary sclerosing cholangitis with partial steroid responsiveness: a case report.原发性硬化性胆管炎伴部分类固醇反应性：一例报告
Fujita Med J. 2023 May;9(2):154-159. doi: 10.20407/fmj.2022-012. Epub 2022 Jul 22.
9
Cholangiocarcinoma complicating primary sclerosing cholangitis.胆管癌合并原发性硬化性胆管炎。
Ann Surg. 1991 Jan;213(1):21-5. doi: 10.1097/00000658-199101000-00004.
10
Sclerosing cholangitis.硬化性胆管炎
Curr Opin Gastroenterol. 2005 May;21(3):348-53. doi: 10.1097/01.mog.0000155359.43763.cc.
引用本文的文献
1
Identifying risk factors of biliary tract cancers using a large Japanese regional insurance claims database.利用一个大型日本地区保险理赔数据库确定胆道癌的风险因素。
Sci Rep. 2025 Jul 8;15(1):24347. doi: 10.1038/s41598-025-09790-6.
2
Development of the natural history component of an early economic model for primary sclerosing cholangitis.原发性硬化性胆管炎早期经济模型中自然史部分的开发。
Orphanet J Rare Dis. 2025 Mar 18;20(1):133. doi: 10.1186/s13023-025-03658-8.
3
Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis.儿童期起病的原发性硬化性胆管炎和自身免疫性硬化性胆管炎至成年期的长期随访
JPGN Rep. 2022 Jun 21;3(3):e220. doi: 10.1097/PG9.0000000000000220. eCollection 2022 Aug.
4
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis.PRIMIS：一项关键性、随机、3 期研究的设计，评估非甾体法尼醇 X 受体激动剂西罗福西安在非肝硬化原发性硬化性胆管炎患者中的安全性和疗效。
BMC Gastroenterol. 2023 Mar 15;23(1):75. doi: 10.1186/s12876-023-02653-2.
5
Primary sclerosing cholangitis-A long night's journey into day.原发性硬化性胆管炎——漫长黑夜后的黎明。
Clin Liver Dis (Hoboken). 2022 Dec 11;20(Suppl 1):21-32. doi: 10.1002/cld.1264. eCollection 2022 Nov.
6
Primary sclerosing cholangitis: review for radiologists.原发性硬化性胆管炎：放射科医师的综述。
Abdom Radiol (NY). 2023 Jan;48(1):136-150. doi: 10.1007/s00261-022-03655-6. Epub 2022 Sep 5.
7
Complexities of the Microbiome: Jaundice in Patient With Ulcerative Colitis.微生物组的复杂性：溃疡性结肠炎患者的黄疸
J Nurse Pract. 2020 Sep;16(8):e133-e136. doi: 10.1016/j.nurpra.2020.04.025. Epub 2020 Aug 2.
8
Geoepidemiologic variation in outcomes of primary sclerosing cholangitis.原发性硬化性胆管炎结局的地理流行病学差异
World J Hepatol. 2020 Apr 27;12(4):116-124. doi: 10.4254/wjh.v12.i4.116.
本文引用的文献
1
Malignancy in primary sclerosing cholangitis: Bile duct, liver, and colon.原发性硬化性胆管炎中的恶性肿瘤：胆管、肝脏和结肠。
Clin Liver Dis (Hoboken). 2014 Apr 28;3(4):83-85. doi: 10.1002/cld.334. eCollection 2014 Apr.
2
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.原发性硬化性胆管炎的全基因组关联研究确定了新的风险位点并量化了与炎症性肠病的遗传关系。
Nat Genet. 2017 Feb;49(2):269-273. doi: 10.1038/ng.3745. Epub 2016 Dec 19.
3
New Therapeutic Strategies for Primary Sclerosing Cholangitis.原发性硬化性胆管炎的新治疗策略
Semin Liver Dis. 2016 Feb;36(1):5-14. doi: 10.1055/s-0035-1571274. Epub 2016 Feb 12.
4
Primary sclerosing cholangitis: a clinical update.原发性硬化性胆管炎：临床新进展。
Br Med Bull. 2015 Jun;114(1):53-64. doi: 10.1093/bmb/ldv019. Epub 2015 May 16.
5
Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC.社论：血清碱性磷酸酶作为原发性硬化性胆管炎预后有用替代标志物作用的进一步证据
Aliment Pharmacol Ther. 2015 Jan;41(1):149-51. doi: 10.1111/apt.13004.
6
Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?).熊去氧胆酸治疗原发性硬化性胆管炎：如果停药有害，那么用药有益（对吗？）
Hepatology. 2014 Sep;60(3):785-8. doi: 10.1002/hep.27180. Epub 2014 Jul 28.
7
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.基于人群的流行病学、恶性肿瘤风险与原发性硬化性胆管炎的结局。
Hepatology. 2013 Dec;58(6):2045-55. doi: 10.1002/hep.26565. Epub 2013 Oct 17.
8
The genetics of complex cholestatic disorders.复杂胆汁淤积性疾病的遗传学。
Gastroenterology. 2013 Jun;144(7):1357-74. doi: 10.1053/j.gastro.2013.03.053. Epub 2013 Apr 10.
9
Diagnosis and management of primary sclerosing cholangitis.原发性硬化性胆管炎的诊断与管理
Hepatology. 2010 Feb;51(2):660-78. doi: 10.1002/hep.23294.
10
EASL Clinical Practice Guidelines: management of cholestatic liver diseases.欧洲肝脏研究学会临床实践指南：胆汁淤积性肝病的管理
J Hepatol. 2009 Aug;51(2):237-67. doi: 10.1016/j.jhep.2009.04.009. Epub 2009 Jun 6.
Zotero 插件